Jason Johnson

Partner & CHS Managing Director

Overview

Jason Johnson is a partner in Crowell’s Health Care and Privacy & Cybersecurity Groups, where he draws on his experience as a former research scientist to advise clients on complex compliance, legal, regulatory, and transactional matters. He helps clients in the health care and life sciences industries navigate data privacy and cybersecurity issues under U.S. and European law. He also offers strategic insights to assist clients with product development, marketing, clinical research, and other core business initiatives.

Jason is well-versed on even the most complicated regulatory challenges that his clients face. As a former research scientist in academic and pharmaceutical settings, as well as a clinical research monitor who trained physicians, Jason knows the rules firsthand. He employs this knowledge to assist clients with the full range of issues that arise in the research and development process, including drafting and negotiating research, clinical trial, licensing, and manufacturing agreements; intellectual property and technology transfer issues; collection, transfer and sharing of data, including patient registries and bio-repositories; and advising clients on mergers and acquisitions and related transactions. Jason’s clients in this area include academic medical centers, healthcare technology companies, emerging to late stage biotechnology companies, pharmaceutical and medical device companies, and other health care and research organizations.

In addition, Jason counsels hospitals, home health agencies, and other health care providers on state and federal fraud and abuse issues including the Stark Law and the Anti-Kickback Statute.

Jason also has extensive experience as a patent litigator. He represented pharmaceutical and chemical companies in Hatch-Waxman litigation for more than 11 years. Jason has substantial experience in counseling clients regarding patent portfolio management, including reviewing patent portfolios, providing advice on the strength or weakness of those portfolios and what actions should be taken, if any, to best protect the company’s products and assets.

Career & Education

|
    • University of North Carolina at Chapel Hill, B.S.
    • Franklin Pierce Law Center, J.D., magna cum laude
    • University of North Carolina at Chapel Hill, B.S.
    • Franklin Pierce Law Center, J.D., magna cum laude
    • New York
    • U.S. District Court for the Eastern District of New York
    • U.S. District Court for the Southern District of New York
    • U.S. Patent and Trademark Office (USPTO)
    • New York
    • U.S. District Court for the Eastern District of New York
    • U.S. District Court for the Southern District of New York
    • U.S. Patent and Trademark Office (USPTO)
    • American Health Lawyers Association
    • New York State Bar Association
    • American Bar Association
    • American Health Lawyers Association
    • New York State Bar Association
    • American Bar Association

Jason's Insights

Client Alert | 9 min read | 11.06.24

Proposed Rule on Protecting Bulk Sensitive Data and Its Impact on Health Care

On October 29, 2024, the Department of Justice (DOJ) published a Notice of Proposed Rulemaking (NPRM) to implement Executive Order 14117 “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern” (the E.O.).  The E.O. addresses the national security threat posed by the continued effort of certain countries of concern to access and exploit certain kinds of Americans’ sensitive personal data, which includes health data and genetic data. This builds on DOJ’s Advance Notice of Proposed Rulemaking (ANPRM) published on March 5.  Comments are due on November 29, 2024....

|

Jason's Insights

Client Alert | 9 min read | 11.06.24

Proposed Rule on Protecting Bulk Sensitive Data and Its Impact on Health Care

On October 29, 2024, the Department of Justice (DOJ) published a Notice of Proposed Rulemaking (NPRM) to implement Executive Order 14117 “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern” (the E.O.).  The E.O. addresses the national security threat posed by the continued effort of certain countries of concern to access and exploit certain kinds of Americans’ sensitive personal data, which includes health data and genetic data. This builds on DOJ’s Advance Notice of Proposed Rulemaking (ANPRM) published on March 5.  Comments are due on November 29, 2024....